MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 26.5066

Change

-0.04 (-0.14)%

Market Cap

N/A

Volume

27.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-1.45 (-2.65%)

USD 54.00B
QQQM Invesco NASDAQ 100 ETF

+0.08 (+0.04%)

USD 38.88B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.04 (+0.07%)

USD 20.37B
ACWI iShares MSCI ACWI ETF

+0.01 (+0.01%)

USD 19.56B
CGABL The Carlyle Group Inc. 4.625% ..

-0.03 (-0.16%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

-0.17 (-0.24%)

USD 5.86B
TSLL Direxion Shares ETF Trust - Di..

+0.04 (+0.15%)

USD 5.32B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.02 (+0.04%)

USD 4.54B
ETHA iShares Ethereum Trust ETF

-0.81 (-3.16%)

USD 3.54B
USCL iShares Climate Conscious & Tr..

-0.01 (-0.01%)

USD 2.29B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.44% 76% C+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.44% 76% C+ 64% D
Trailing 12 Months  
Capital Gain -8.41% 18% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.41% 17% F 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.38% 43% F 39% F
Dividend Return 0.38% 35% F 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 2.63% 92% A 98% N/A
Risk Adjusted Return 14.41% 40% F 45% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector